Hypertensive Chronic Kidney Disease in a Cat with Financial Limits
A 9-year-old neutered male domestic shorthair cat is presented for 3 months of progressive weight loss, reduced appetite, and occasional vomiting. Weight is 3.6 kg, down from 4.4 kg. Physical examination shows BCS 3/9, mild dehydration, and no palpable thyroid slip. Systolic blood pressure by Doppler is 185 mmHg on two measurements. Laboratory results: creatinine 3.4 mg/dL, BUN 48 mg/dL, SDMA 28 µg/dL, USG 1.017, UPC 0.45, potassium 3.6 mEq/L, phosphate 6.2 mg/dL, and HCT 32%. The owner has a fixed budget, declines referral and advanced imaging, and asks whether to start blood pressure medication, a renal diet, or a phosphate binder first, and how to monitor at home.
1. How would you classify this cat's chronic kidney disease and hypertension, and what are the immediate priorities given the owner's budget?
Read the worked answer
- CKD stage: IRIS stage 3 based on creatinine 3.4 mg/dL (stage 3 is 2.9–5.0). The low USG and SDMA support chronic disease.
- Hypertension: systolic 185 mmHg is consistent with hypertension; target is generally <160 mmHg. Two readings were obtained, which strengthens the diagnosis.
- Proteinuria: UPC 0.45 is above the 0.4 threshold, so this is proteinuric CKD.
- Other problems: hyperphosphatemia and borderline hypokalemia.
Immediate priorities: confirm blood pressure trends, start antihypertensive therapy, address phosphate and protein intake with a renal diet, correct dehydration if clinically needed, and monitor potassium. Because the owner has limited funds, avoid low-yield imaging and focus on interventions most likely to prevent target-organ damage-especially retinal detachment and progressive kidney injury. Amlodipine is the practical first-line antihypertensive in cats; a renal diet is the most cost-effective way to address phosphate, proteinuria, and CKD progression. A phosphate binder can be added later if diet alone does not control phosphate.
2. The owner can afford only two interventions this month. Which two do you recommend and why? What would you defer?
Read the worked answer
Recommend: (1) amlodipine and (2) a renal diet.
- Amlodipine: hypertension is immediately vision- and organ-threatening. Controlling systolic pressure reduces the risk of retinal detachment, neurologic signs, and further renal injury. It is relatively inexpensive and can be monitored with recheck blood pressure.
- Renal diet: this addresses phosphate load, proteinuria, and CKD progression. It is more cost-effective than combining a normal diet with a phosphate binder in most cases, and it also helps control proteinuria.
Defer: a phosphate binder and benazepril initially. Recheck phosphate and UPC after the diet and blood pressure control. If proteinuria persists after hypertension is controlled, adding an ACE inhibitor is reasonable. If phosphate remains high despite diet, add a binder. Explain that the renal diet must be transitioned slowly to avoid food refusal, and that amlodipine dosing may need adjustment based on recheck blood pressure.
3. What monitoring plan and red flags would you give the owner, given that frequent rechecks are difficult?
Read the worked answer
Recheck plan:
- Blood pressure 7–14 days after starting amlodipine; increase the dose if systolic pressure remains >160 mmHg and the cat is stable.
- Renal panel and electrolytes in 3–4 weeks, then every 2–3 months if stable.
- UPC and phosphate once the cat is stable on the diet, or sooner if proteinuria or phosphate is worsening.
Home monitoring: weekly body weight, appetite, water intake, litter box output, activity, and attitude. Ask the owner to watch for sudden blindness, bumping into objects, dilated pupils, seizures, ataxia, weakness, vomiting, or complete anorexia.
Judgment point: in a budget-limited setting, prioritize blood pressure and weight/appetite over perfect laboratory follow-up. If the cat becomes blind or neurologic, immediate recheck is needed even if the owner had planned to wait. Avoid NSAIDs and other nephrotoxic drugs.